Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

BackgroundPneumonia causes about 0.9 million deaths worldwide each year. The World Health Organization (WHO) guidelines for the standard management of severe pneumonia requires parenteral ampicillin every 6 hours and once-daily parenteral gentamicin for 5 to 7 days. Although...

Full description

Bibliographic Details
Main Authors: Shahrin, Lubaba, Chisti, Mohammod Jobayer, Shahid, Abu Sadat Mohammad Sayeem Bin, Rahman, Abu Sayem Mirza Mohammad Hasibur, Islam, Md. Zahidul, Afroze, Farzana, Huq, Sayeeda, Ahmed, Tahmeed
Format: Article
Language:English
Published: JMIR Publications 2020-11-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2020/11/e17735

Internet

https://www.researchprotocols.org/2020/11/e17735

Similar Items